Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission
Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission
NCT ID: NCT02324439 Phase: PHASE1 Status: COMPLETED Enrollment: 15 Completion: 2021-03
Conditions
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
Interventions
Omega Nutrition cold-milled flaxseeds
Summary
This is a phase 0/phase I feasibility trial to test the hypothesis that flaxseed supplementation is an effective maintenance therapy for patients with ovarian cancer who are in clinical remission following platinum-based regimens. The investigators further hypothesize levels of estrogen metabolites and prostaglandin E2 in this patient population will correlate with recurrence of disease, extent of tumor burden, invasion and metastasis.
Primary Outcome
Feasibility of consuming 20g of flaxseed per day